Hormone Replacement Therapy for Women: The Complete Guide

What Is Hormone Replacement Therapy for Women?

Hormone replacement therapy (HRT) — also called menopausal hormone therapy (MHT) — supplements declining estrogen, progesterone, and sometimes testosterone as women approach and pass through menopause, typically between ages 45 and 55. The resulting symptoms — hot flashes, night sweats, mood changes, vaginal dryness, bone loss, and sleep disruption — can significantly affect quality of life. HRT is the most effective treatment for these symptoms, with a favorable risk-benefit profile for most healthy women under 60 or within 10 years of menopause onset.

Why Hormones Decline — and Why It Matters

Estrogen and progesterone are produced primarily by the ovaries. During perimenopause, production gradually decreases. By confirmed menopause, estrogen levels have dropped by 90% or more. This affects virtually every body system:

• Brain: Estrogen supports serotonin and dopamine; its decline contributes to mood swings, anxiety, and brain fog.
• Bones: Estrogen inhibits bone resorption; low levels accelerate osteoporosis risk.
• Cardiovascular system: Estrogen supports arterial flexibility and lipid profiles.
• Urogenital tissue: Vaginal walls thin and lubrication decreases — now called genitourinary syndrome of menopause (GSM).
• Sleep: Progesterone has sedative properties; its loss contributes to insomnia.
• Metabolism: Estrogen influences insulin sensitivity and fat distribution; its decline contributes to central weight gain.

Types of HRT: Your Options

Estrogen Therapy

For women without a uterus, estrogen-only therapy is the most potent treatment for hot flashes and GSM. Forms include oral tablets, transdermal patches and gels (preferred for lower clot risk), and local vaginal preparations for GSM-specific treatment.

Combined Estrogen-Progesterone Therapy

Women with a uterus must take progestogen alongside estrogen to prevent endometrial hyperplasia. Options include synthetic progestins or bioidentical micronized progesterone — the latter may have a better breast and cardiovascular safety profile based on emerging data.

Testosterone for Women

Low-dose testosterone may be added for women with low libido (HSDD). While not yet FDA-approved specifically for women, evidence supports its efficacy. Learn more in our guide on testosterone therapy for women.

Bioidentical Hormones

Bioidentical hormones are chemically identical to those the body naturally produces. Some are FDA-approved; others come from compounding pharmacies. See our guide on bioidentical hormone therapy for details.

Benefits by Symptom

Hot Flashes and Night Sweats

HRT reduces vasomotor symptom frequency and severity by 75–90% in most women — no other treatment comes close.

Vaginal and Sexual Health

Low-dose vaginal estrogen effectively treats GSM and is safe even for many women with breast cancer history when used locally at low doses.

Sleep and Mood

Many women report dramatic improvements in sleep quality and emotional stability on HRT, particularly when progesterone is included. Evidence shows reductions in perimenopausal depression symptoms.

Bone Protection

HRT is FDA-approved for osteoporosis prevention and significantly reduces fracture risk during treatment.

Metabolic Benefits

Estrogen therapy is associated with reduced type 2 diabetes risk, improved insulin sensitivity, and favorable effects on visceral fat and body composition. If weight management is a challenge, explore our weight loss programs alongside hormone optimization.

Understanding the Real Risks

The WHI Study in Context

The 2002 Women's Health Initiative (WHI) study raised alarms about HRT and breast cancer using older women (average age 63) on oral conjugated equine estrogen plus synthetic progestin. Re-analyses showed risks were largely confined to older women starting HRT more than 10 years post-menopause — a very different population than typical menopause candidates.

Breast Cancer Risk

The 2019 Collaborative Group analysis found approximately one extra breast cancer case per 50 women using combined HRT for five years — a real but modest risk that must be weighed against substantial symptom and long-term health benefits. Estrogen-only therapy (post-hysterectomy) may actually reduce breast cancer risk in some analyses.

Blood Clot Risk

Oral estrogen increases VTE risk. Transdermal estrogen does not carry the same risk — making it the preferred route for women with clot risk factors. This is an important distinction that many older studies and media reports fail to make.

The Timing Hypothesis

Evidence consistently supports starting HRT within 10 years of menopause onset (before age 60) to maximize cardiovascular and cognitive benefits. Starting later does not carry the same benefits and may increase certain risks.

Who Is a Good Candidate?

Licensed providers evaluate based on age and time since menopause, symptom severity, personal and family medical history (breast cancer, blood clots, cardiovascular disease), bone density, and lifestyle factors. Most healthy women under 60 with bothersome symptoms are candidates — but individualized assessment is essential.

How Long Should You Take HRT?

There is no universal time limit. Current guidelines recommend the lowest effective dose for as long as symptoms persist and benefits outweigh risks, with annual review. Many women choose to continue HRT for years — even decades — for ongoing bone protection and quality of life.

Getting Started With Telehealth HRT

Modern telehealth platforms make accessing evidence-based HRT simpler than ever. A licensed provider can review your labs, symptoms, and medical history — all from home. Prescriptions go to local pharmacies or specialty compounding pharmacies as appropriate. If menopausal symptoms affect your daily life, evidence-based, individualized hormone therapy is available and accessible.